Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YG4I
|
|||
| Former ID |
DCL001069
|
|||
| Drug Name |
Bevasiranib
|
|||
| Drug Type |
siRNA drug
|
|||
| Indication | Exudative age-related macular degeneration [ICD-11: 9B78.3Z; ICD-9: 362.5] | Discontinued in Phase 3 | [1] | |
| Therapeutic Class |
siRNA
|
|||
| Company |
Opko Health
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2011 Pipeline of Acuity Pharmaceuticals. | |||
| REF 2 | Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.